Clinical Trial Update: A Study to Assess the Efficacy and Safety of Paricalcitol in the Treatment of Chronic Kidney Disease With Secondary Hyperparathyroidism [Phase 3]

View source ↗

Summary

Phase 3 clinical trial assessing paricalcitol for secondary hyperparathyroidism in chronic kidney disease; status not specified.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Kidney Disease
• Hyperparathyroidism

Drugs mentioned

• Paricalcitol (paricalcitol)

Snippet

Sponsor: Chengdu Suncadia Medicine Co., Ltd. | Conditions: Secondary Hyperparathyroidism | Phase 3 | Status: UNKNOWN